ALFA Filings
Every announcement, straight from the exchange
Every Ajanta Pharma share pledge announcement on NSE and BSE, newest first, each with its own page.
Time
16 announcements with these filters
Ajanta Pharma promoter Aayush Agrawal (trustee) created a pledge on 30,000 equity shares. The pledge was made as a top-up call due to share price reduction.
Promoter Aayush Agrawal Trust created pledge on 4,60,000 Ajanta Pharma shares. The pledge secures an NCD issue in favor of CTL Trusteeship Ltd.
CTL Trusteeship Limited reported a pledge creation on 26,21,067 shares (2.10%) of Ajanta Pharma Limited to secure debentures worth Rs. 3,873 Crore. The shares act as collateral for NCDs issued by Lenexis Foodworks and Inspira Realty.
Ajanta Pharma promoter Aayush Agrawal Trust released a pledge on 98,185 equity shares. The release followed loan repayment to Aditya Birla Capital Ltd.
Aayush Agrawal (Trustee of Aayush Agrawal Trust) has released a pledge on 1,736,353 equity shares of Ajanta Pharma Limited. This follows loan repayment.
Promoter Aayush Agrawal Trust released pledge on 9.76 lakh shares and created a new pledge on 9.20 lakh shares of Ajanta Pharma Limited.
Promoter Ravi Agrawal, as trustee of Ravi Agrawal Trust, released a pledge on 54,796 equity shares of Ajanta Pharma Limited due to excess pledge.
Ajanta Pharma promoter Aayush Agrawal released a pledge of 21,61,067 shares and simultaneously created a new pledge for the same number of shares.
Ajanta Pharma revised its SAST filing, indicating pledged promoter shares as security for non‑convertible debentures. No monetary value of the pledge is disclosed.
Ajanta Pharma pledged shares as security for debentures totaling ₹3,873 crore. The pledge benefits CTL Trusteeship Ltd as common security trustee.
Promoter Ravi Agrawal Trust released pledges on 17,32,792 equity shares of Ajanta Pharma. The release was executed on June 25, 2026.
Promoter Aayush Agrawal created a pledge over 1,111,111 Ajanta Pharma shares for a new loan. The pledge increases promoter leverage and warrants monitoring.
Ajanta Pharma promoter Ravi Agrawal created a pledge on 2,20,000 shares and released 2,60,000 shares. The creation was driven by business re-financing requirements.
Ajanta Pharma promoter Aayush Agrawal released a pledge on 1,92,500 shares following loan repayment. This reduction in encumbered shares improves the promoter's skin-in-the-game.
Promoter Aayush Agrawal pledged and released 2,86,213 shares of Ajanta Pharma Limited. The transactions relate to new loan creation and existing loan repayment.
Ajanta Pharma Limited promoter Aayush Agrawal, trustee of Aayush Agrawal Trust, has created a pledge on 3,85,000 equity shares (0.31% of share capital) on March 30, 2026. This action was taken to increase an existing loan facility. Investors should monitor promoter pledge levels as they indicate financial leverage.